Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DILTIAZEM XC | 360MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-07 | 2024-04-25 | 221546 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-05 | 2024-04-25 | 224445 |
| ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-28 | 2024-04-25 | 223862 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-01-11 | 2024-04-25 | 215751 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2024-01-11 | 2024-04-25 | 215760 |
| TEVA-TADALAFIL | 2.5MG | TABLET | Actual shortage | 2024-04-25 | 2024-04-25 | 226177 |
| ACT DEXTROAMPHETAMINE SR | 10MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-02-01 | 2024-04-25 | 218145 |
| ACT DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2024-01-25 | 2024-04-25 | 217240 |
| TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-08-03 | 2024-04-25 | 200864 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218123 |
| TEVA-SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-21 | 2024-04-25 | 222938 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223844 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218129 |
| TEVA-FLUVASTATIN | 20MG | CAPSULE | Resolved | 2023-11-03 | 2024-04-25 | 209111 |
| TEVA-TELMISARTAN | 40MG | TABLET | Resolved | 2023-07-20 | 2024-04-25 | 199393 |
| TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2024-01-11 | 2024-04-25 | 215728 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-04-29 | 166975 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-04-29 | 166972 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-04-29 | 166969 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
| TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
| ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
| ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65292 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |